Since they positively correlate not only with VEGF expression and BC vascularity but also with BC growth rate, invasiveness, and metastasis, FOXP3 levels have been thought to be capable of monitoring BC clinical progression [110]. The gene discussed is VEGFA; the disease is breast cancer.